JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Efficacy and Safety of Dose Increase From 40 mg/d to 80 mg/d of Lurasidone in Patients With Schizophrenia: A Post Hoc Analysis of Extension Trial
Takeuchi H and Uchida H
The primary objective of this study was to evaluate the efficacy and safety of increasing the dose of lurasidone from 40 mg/d to 80 mg/d in patients with schizophrenia.
Broad-Spectrum Micronutrients or Antidepressants for Antenatal Depression: Effect on Maternal and Infant Birth Outcomes in an Observational Secondary Analysis of NUTRIMUM
Heaton JL, Campbell SA, Bradley HA, Mulder RT, Dixon L, Henderson J and Rucklidge JJ
One-fifth of women experience antenatal depression. Untreated antenatal depression is associated with increased risk of adverse birth outcomes. This study investigated the effect of broad-spectrum micronutrients (BSM; vitamins and minerals), used to treat antenatal depression (NUTRIMUM trial), on birth outcomes.
The Treatment of Iatrogenic Anorgasmia in a Male Patient on Clozapine for Treatment-Resistant Schizophrenia: The Role of Pseudoephedrine
O'Connell P and Alsaffar M
Ischemic Priapism With Therapeutic Serum Concentrations of Psychotropic Medications
Inoue F, Okazaki Y, Huh K, Ichiba T and Namera A
Ethics in Psychedelic Science: Promises and Responsibilities
Sisti D
Recurrent Pancreatitis Associated With Atomoxetine Use in a 9-Year-Old Boy: A Case Report
Bulut ÖF and Karayağmurlu A
Fluoxetine and Sertraline Inhibit Height Growth and Growth Hormone Signaling During Puberty
Calarge C, Amushie C, Dinh S, Mills JA, Devaraj S, Barba-Villalobos G, Nguyen J, Garcia JM, Sisley S, Bacha F and Zemel B
The aim of this study was to examine the effect of fluoxetine and sertraline on height growth and insulin-like growth factor-1 (IGF-1) during puberty.
Antipsychotic Polypharmacy in Time Course: Evidence for a Cross-titration Trap
Lochmann van Bennekom MWH, Gijsman HJ, IntHout J and Verkes RJ
Antipsychotic polypharmacy (APP) is controversial yet applied in 20% of patients with psychotic disorders. We investigated indications for initiating and continuing APP, including the contribution of unfinished cross-titrations.
Psychopharmacologic Laziness
Rothschild AJ
Aripiprazole-Associated QT Prolongation in a Healthy Study Volunteer: A Case Report and Literature Review
Chapman GE, Osugo M, de Marvao A and Howes OD
Ketamine. The Story of Modern Psychiatry's Most Fascinating Molecule
Balon R
Question: Do You Have Suggestions for Managing a Patient With Bipolar II Disorder, Binge Eating Disorder, and Obesity Who Stops Medications Fearing Weight Gain?
McElroy SL
Myocarditis on Clozapine 50 mg/d in a Patient With Parkinson's Disease
Skoble L, Kutz S and Friedman JH
Suicidal Ideation and Self-harming Thoughts With Valbenazine Use: A Case Report
Neeman J, Lang SE and Jiao J
Lumbosacral Plexopathy in Clozapine Overdose: A Case Report
Ozudogru Celik T
Bipolar Disorder in a Young Adult With Thalassemia Major With Sequential Development of Neuroleptic Malignant Syndrome and Serotonin Syndrome
Ragul Kalaimathi K, Thakur MR and Garg B
Mechanisms of Drug-Associated Burning Mouth Syndrome
Nagamine T
Health Alert: Microdose Products Leading to Acute Illness and Hospitalizations Across the United States
Nguyen E, Qavi A and Tran MH
Clozapine-Associated Eosinophilia at a Movement Disorders Clinic
Mohammadzadeh N, Gopalakrishnan B and Friedman JH
Transitioning From a Standard Low-Dose to a Rapid Low-Dose Buprenorphine Initiation in a Hospital Setting-A Case Report
Williams JB, Dawson KR, Le PD and Tahir H
Successful Management of ECT-Resistant Interictal Psychosis With Clozapine: A Case Report
Mitoma R, Hirano S and Nakao T